Examination of safety and efficacy of pulmonary rehabilitation for patients with pulmonary hypertension: Appropriate exercise prescription on pulmonary hypertension during exercise

Sugiura Toshihiko0 sites21 target enrollmentAugust 13, 2021

Overview

No summary available.

Registry

who.int

Start Date

August 13, 2021

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Sugiura Toshihiko

•1\) Patients diagnosed with pulmonary hypertension (resting mPAP of 20 mmHg or more by right heart catheterization)
•2\) Patients who have already been treated with vasodilators for pulmonary hypertension and have not changed their treatment for more than 3 months
•3\) Patients with resting mPAP \< 35 mmHg and PVR not increased by more than 15% compared with the previous right heart catheterization.
•4\) Patients who underwent a cardiopulmonary exercise stress test during the previous right heart catheterization
•5\) Patients aged 20 years or older at the time of consent.
•6\) Patients who have received sufficient explanation for participation in the study and have given written consent of their own free will with sufficient understanding.

•1\) Patients with poorly controlled heart failure, heart disease, or arrhythmia
•2\) Patients with osteoarticular diseases or neuromuscular diseases that affect ADL
•3\) Patients with mental illness or cognitive decline that makes it difficult to perform the test safely and accurately